SHARON BROWN: Open Payments
NPI 1710098413 · BLUE RIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 65 payments from 14 companies in 2025. Trend: 2023 $658 · 2024 $1,005 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $405 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 20 | $211 |
| Regeneron Healthcare Solutions, Inc. | 6 | $179 |
| Janssen Biotech, Inc. | 5 | $82 |
| UCB, Inc. | 4 | $69 |
| Lilly USA, LLC | 3 | $58 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $51 |
| BioWound Solutions, Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $35 |
| Incyte Corporation | 1 | $18 |
Products named: COSENTYX, ILUMYA, DUPIXENT, TREMFYA, Bimzelx, TALTZ, bio-ConneKt, SKYRIZI.
Industry payments across GA — which companies pay providers there.
